In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



This article was originally published in The Rose Sheet

Executive Summary

Dermatologist Pamela Wexler, MD, Beth Israel Medical Center, signs agreement to consult on the "development and promotion" of new skin care and cosmetics products slated to bow in late 2000 and early 2001, the company announces June 28. Wexler is a member of the American Board of Dermatology and American Board of Internal Medicine. The products will contain Senetek's patented Kinetin technology; Revlon signed a $3 mil. licensing agreement with Senetek in June (1"The Rose Sheet" June 19, In Brief)

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts